As Basepaws sees it, a deeper understanding of the genetic factors that contribute to feline longevity can support cats to live longer, but more importantly, do so in ways that help them enjoy their golden years with fewer instances of pain and illness. To make this a reality for all cats, Basepaws initiated a longevity research partnership with Ernie Ward, DVM, CVFT, founder of Project 25, which aims to extend feline life expectancy by 25 percent by the year 2025.
Basepaws has added new genetic health and trait markers to its flagship Breed + Health Cat DNA test. In the Health Marker section of your cat’s report, Basepaws provides their results related to 43 genetic disorders that are represented by 65 health markers.
Basepaws is excited to announce that it is adding over 80 genetic health and trait markers to its flagship at-home Breed + Health Cat DNA test. In total, the test will now screen your cat for over 120 markers and will offer features that no other direct-to-consumer (D2C) test provides.
In the spirit of National Pet Wellness month this October, Basepaws announced its commitment to raising awareness about chronic kidney disease (CKD)—a major feline health issue from which one in 30 cats suffer. With our concurrent launch of the inaugural Basepaws “Feline Kidney Disease Awareness” month, we would like to take this opportunity to share details about our game-changing feline oral microbiome and genetics health research for the early detection of CKD.
Chronic Kidney Disease (CKD) is a disease common in both cats and people. If your veterinarian has determined that kidney damage has been ongoing for more than 3 months, it is considered chronic and will require close monitoring and intervention.
